The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis. (Q50072148)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 January 2018

Language	Label	Description	Also known as
English	The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis.	scientific article published on 12 January 2018

Statements

scholarly article

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

0 references

The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis. (English)

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

liver transplantation

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Zheng-Guang Xu

1

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

Cheng-Jie Ye

2

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

Lin-Xun Liu

3

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

Gang Wu

4

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

Zhan-Xue Zhao

5

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

Yong-Zhen Wang

6

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

Bing-Qiang Shi

7

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

Yong-Hong Wang

8

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

publication date

12 January 2018

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

Biomarkers in Medicine

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

12

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

2

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

189-199

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Comparisons of financial and short-term outcomes between laparoscopic and open hepatectomy: benefits for patients and hospitals.

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Surgical management of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasis

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma.

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Inflammation-based Prognostic Score in Patients with Living Donor Liver Transplantation for Hepatocellular Carcinoma.

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer.

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Inflammatory markers as selection criteria of hepatocellular carcinoma in living-donor liver transplantation

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Retracted: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Quantitative synthesis in systematic reviews

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Neutrophil-lymphocyte ratio is useful for the prognosis of patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma: a meta-analysis

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Prognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Evaluation methods for pretransplant oncologic markers and their prognostic impacts in patient undergoing living donor liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Postoperative changes in neutrophil-to-lymphocyte ratio and platelet count: A simple prognostic predictor for adult-to-adult living donor liver transplantation.

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Preoperative neutrophil-to-lymphocyte ratio as a predictor of survival after reductive surgery plus percutaneous isolated hepatic perfusion for hepatocellular carcinoma: a retrospective analysis

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Neutrophil to lymphocyte ratio as an indicator of the malignant behaviour of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival.

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Elevated preoperative neutrophil-to-lymphocyte ratio can predict poor survival in early stage gastric cancer patients receiving radical gastrectomy: The Fujian prospective investigation of cancer (FIESTA) study

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FBMM-2017-0307

21 January 2018

Identifiers

10.2217/BMM-2017-0307

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

1 reference

Europe PubMed Central

24 February 2018

http://europepmc.org/abstract/MED/29327595

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50072148&oldid=1500942928"